Isolated tricuspid regurgitation secondary to annular dilatation: a rare case report
Abstract
Isolated tricuspid regurgitation (TR) which is due to primary valvular pathology is a rare occurrence. Very few cases have been reported from India. Pathology may involve tricuspid valve leaflets, subvalvular apparatus or valve annulus. Tricuspid regurgitation is usually functional and associated with rheumatic heart disease or dilated cardiomyopathy. Here we are presenting a case of 55 years old man with primary tricuspid regurgitation secondary to dilatation of tricuspid annulus. Patient was started on diuretics and anticoagulation, 50% reduction in symptoms was noted after one week of treatment. In the given clinical context cause of this isolated tricuspid regurgitation appears to be secondary to annular dilatation. Patient was referred for myocardial biopsy and Annuloplasty. Patient’s course seems to be rapidly progressive once he presents with the symptoms. But with the advances in percutaneous interventions there is a hope for these patients to be treated with significant clinical improvements.
Downloads
References
2. Frater R. Tricuspid insufficiency. J Thorac Cardiovasc Surg. 2001 Sep;122(3):427-9. Review.
3. Messika-Zeitoun D, Thomson H, Bellamy M, Scott C, Tribouilloy C, Dearani J, Tajik AJ, Schaff H, Enriquez-Sarano M. Medical and surgical outcome of tricuspid regurgitation caused by flail leaflets. J Thorac Cardiovasc Surg. 2004, Aug;128(2):296-302.
4. Kara I, Koksal C, Erkin A, Sacli H, Demirtas M, Percin B, Diler MS, Kirali K. Outcomes of Mild to Moderate Functional Tricuspid Regurgitation in Patients Undergoing Mitral Valve Operations: A Meta-Analysis of 2,488 Patients. Ann Thorac Surg. 2015 Dec;100(6):2398-407. doi: 10.1016/j.athoracsur.2015.07.024. Epub 2015 Oct 31. Review.
5. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, O'Gara PT, Ruiz CE, Skubas NJ, Sorajja P, Sundt TM 3rd, Thomas JD; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014 Jun 10;63(22):e57-185. doi: 10.1016/j.jacc.2014.02.536. Epub 2014 Mar 3. Erratum in: J Am Coll Cardiol. 2014 Jun 10;63(22):2489. Dosage error in article text.
6. Starck CT, Kempfert J, Falk V. Tricuspid valve interventions: surgical techniques and outcomes. EuroIntervention. 2015 Sep;11 Suppl W:W128-32. doi: 10.4244/EIJV11SWA36. Review.
7. Campelo-Parada F, Perlman G, Philippon F, Ye J, Thompson C, Bédard E,Abdul-Jawad Altisent O, Del Trigo M, Leipsic J, Blanke P, Dvir D, Puri R, Webb JG, Rodés-Cabau J. First-in-Man Experience of a Novel Transcatheter Repair System for Treating Severe Tricuspid Regurgitation. J Am Coll Cardiol. 2015 Dec 8;66(22):2475-83. doi: 10.1016/j.jacc.2015.09.068. Epub 2015 Oct 11.
8. Reddy YM, Gunda S, Vallakati A, Kanmanthareddy A, Pillarisetti J, Atkins D, Bommana S, Emert MP, Pimentel R, Dendi R, Berenbom LD, Lakkireddy D. Impact of Tricuspid Regurgitation on the Success of Atrioventricular Node Ablation for Rate Control in Patients With Atrial Fibrillation: The Node Blast Study. Am J Cardiol. 2015 Sep 15;116(6):900-3. doi: 10.1016/j.amjcard.2015.06.017. Epub 2015 Jun 24.